Tuesday, Jan 18, 2022
Outlook.com

Indian Pharma Companies

Indian Pharma Industry Estimated To Grow 9-11% in 2021-22: ICRA

Indian Pharma Industry Estimated To Grow 9-11% in 2021-22: ICRA

04 January 2022

ICRA said revenue growth was moderate at 6.4 per cent in the second quarter of FY22, down from 16 per cent in the first quarter of 2021-22.

Alembic Pharma Gets USFDA Approval For Generic Drug

Alembic Pharma Gets USFDA Approval For Generic Drug

04 January 2022

The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD) Doryx Tablets, 75 mg, 100 mg, 150 mg, and 200 mg, of Mayne Pharma...


Medplus Health Services Makes Stellar Market Debut Lists At Premium Of 31%

Medplus Health Services shares were in heavy demand during the three day share sale via Initial public offering which ended on December 15.

Govt Expects 4 More Indian Pharma Brands To Begin Vaccine Production By Oct-Nov: Health Minister

Govt Expects 4 More Indian Pharma Brands To Begin Vaccine Production By Oct-Nov: Health Minister

10 January 2022

'Vaccination drive is going on smoothly. It will get more accelerated in the coming days with the ramping up of production by four more Indian companies,' said...


Advertisement
Advertisement
Advertisement

Opinion

Indian Pharma Industry Estimated To Grow 9-11% in 2021-22: ICRA

Indian Pharma Industry Estimated To Grow 9-11% in 2021-22: ICRA

ICRA said revenue growth was moderate at 6.4 per cent in the second quarter of FY22, down from 16 per cent in the first quarter of 2021-22.

04 January 2022
Alembic Pharma Gets USFDA Approval For Generic Drug

Alembic Pharma Gets USFDA Approval For Generic Drug

The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD) Doryx Tablets, 75 mg, 100 mg, 150 mg, and 200 mg, of Mayne Pharma International Pty Ltd (Mayne).

04 January 2022
Medplus Health Services Makes Stellar Market Debut Lists At Premium Of 31%

Medplus Health Services Makes Stellar Market Debut Lists At Premium Of 31%

Medplus Health Services shares were in heavy demand during the three day share sale via Initial public offering which ended on December 15.

12 January 2022
Govt Expects 4 More Indian Pharma Brands To Begin Vaccine Production By Oct-Nov: Health Minister

Govt Expects 4 More Indian Pharma Brands To Begin Vaccine Production By Oct-Nov: Health Minister

'Vaccination drive is going on smoothly. It will get more accelerated in the coming days with the ramping up of production by four more Indian companies,' said Union Health Minister Mansukh Mandaviya

10 January 2022
Advertisement
Advertisement